SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000031
Filing Date
2019-04-11
Accepted
2019-04-11 17:29:15
Documents
4
Period of Report
2019-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201904118xkdoc.htm 8-K 42145
2 EXHIBIT 10.1 pdli-201904118xkex101.htm EX-10.1 596206
3 PRESS RELEASE pdli-201904118xkex991.htm EX-99.1 15644
4 pdllogoa18.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000031.txt   824670
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 19744532
SIC: 2836 Biological Products, (No Diagnostic Substances)